Cargando…
Risk factors for modified vaccine effectiveness of the live attenuated zoster vaccine among the elderly in England()
BACKGROUND: The United Kingdom introduced routine vaccination with the live-attenuated zoster vaccine for 70 year-olds in 2013, with the vaccine also offered to 79 year-olds as part of a catch-up campaign. In the subsequent years, the catch-up campaign was extended to also include adults aged 78 yea...
Autores principales: | Bollaerts, Kaatje, Alexandridou, Maria, Verstraeten, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668231/ https://www.ncbi.nlm.nih.gov/pubmed/31384729 http://dx.doi.org/10.1016/j.jvacx.2019.100007 |
Ejemplares similares
-
Estimation of Risk of Death Attributable to Acute Gastroenteritis Not Caused by Clostridioides difficile Infection Among Hospitalized Adults in England
por: Alexandridou, Maria, et al.
Publicado: (2021) -
Evaluation of efficacy and effectiveness
of live attenuated zoster vaccine
por: GABUTTI, G., et al.
Publicado: (2014) -
Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
por: Gershon, Anne A, et al.
Publicado: (2021) -
Boosting Immunity in Recipients of Live-Attenuated Zoster
Vaccine
por: Schmid, D. Scott
Publicado: (2016) -
Zoster vaccine live for the prevention of shingles in the elderly patient
por: Zussman, Jamie, et al.
Publicado: (2008)